DE602004010130D1 - Mikroemulsionen und ihre verwendung zur prävention von erkrankungen der atemwege - Google Patents

Mikroemulsionen und ihre verwendung zur prävention von erkrankungen der atemwege

Info

Publication number
DE602004010130D1
DE602004010130D1 DE602004010130T DE602004010130T DE602004010130D1 DE 602004010130 D1 DE602004010130 D1 DE 602004010130D1 DE 602004010130 T DE602004010130 T DE 602004010130T DE 602004010130 T DE602004010130 T DE 602004010130T DE 602004010130 D1 DE602004010130 D1 DE 602004010130D1
Authority
DE
Germany
Prior art keywords
microemulsions
prevention
respiratory diseases
particles
polar lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004010130T
Other languages
English (en)
Other versions
DE602004010130T2 (de
Inventor
Per Wollmer
Morgan Andersson
Lennart Greiff
Thomas Landh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nares AB
Original Assignee
Nares AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0302006A external-priority patent/SE0302006D0/xx
Priority claimed from SE0302005A external-priority patent/SE0302005D0/xx
Application filed by Nares AB filed Critical Nares AB
Publication of DE602004010130D1 publication Critical patent/DE602004010130D1/de
Application granted granted Critical
Publication of DE602004010130T2 publication Critical patent/DE602004010130T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602004010130T 2003-07-07 2004-07-07 Mikroemulsionen und ihre verwendung zur prävention von erkrankungen der atemwege Active DE602004010130T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US48466403P 2003-07-07 2003-07-07
US484664P 2003-07-07
SE0302006A SE0302006D0 (sv) 2003-07-07 2003-07-07 New Microemulsions
SE0302005A SE0302005D0 (sv) 2003-07-07 2003-07-07 New composition
SE0302006 2003-07-07
SE0302005 2003-07-07
PCT/GB2004/002925 WO2005004843A1 (en) 2003-07-07 2004-07-07 Microemulsions and its use for preventing airway diseases

Publications (2)

Publication Number Publication Date
DE602004010130D1 true DE602004010130D1 (de) 2007-12-27
DE602004010130T2 DE602004010130T2 (de) 2008-09-18

Family

ID=34068955

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004010130T Active DE602004010130T2 (de) 2003-07-07 2004-07-07 Mikroemulsionen und ihre verwendung zur prävention von erkrankungen der atemwege

Country Status (7)

Country Link
EP (1) EP1648412B1 (de)
JP (2) JP5037939B2 (de)
AT (1) ATE378038T1 (de)
DE (1) DE602004010130T2 (de)
ES (1) ES2297442T3 (de)
PL (1) PL1648412T3 (de)
WO (1) WO2005004843A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008051186A2 (en) 2005-08-09 2008-05-02 Nanobio Corporation Nanoemulsion containing compositions having ant i -inflammatory activity
ES2348743T3 (es) * 2005-11-22 2010-12-13 Nestec S.A. Emulsion aceite-en-agua y su uso para administrar una funcionalidad.
JP4686763B2 (ja) * 2006-01-31 2011-05-25 独立行政法人産業技術総合研究所 針一体型バイオセンサー
CA2738245A1 (en) * 2008-09-26 2010-04-01 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
AR096459A1 (es) * 2013-06-03 2015-12-30 Tolmar Inc Composiciones de corticosteroides y método de fabricación
KR101743142B1 (ko) 2015-09-09 2017-06-02 강원대학교산학협력단 즉시 사용가능한 마이크로에멀젼 기반의 비강내 면역화용 면역보강제 조성물
CN110200915A (zh) * 2019-05-14 2019-09-06 扬子江药业集团江苏紫龙药业有限公司 一种富马酸卢帕他定乳剂型鼻腔喷雾剂及其制备方法
IT202000024484A1 (it) * 2020-10-16 2022-04-16 Synapticom S R L Soluzione liposomiale con capacita’ di interagire con il particolato atmosferico, nelle cavita' nasali riducendo la velocita' di assorbimento delle particelle inspirate

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
JP3324264B2 (ja) * 1994-03-23 2002-09-17 大正製薬株式会社 鼻洗浄剤
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
CN1159158A (zh) * 1994-05-20 1997-09-10 诺瓦瓦克斯有限公司 抗菌水包油乳液
US5653987A (en) * 1995-05-16 1997-08-05 Modi; Pankaj Liquid formulations for proteinic pharmaceuticals
JP2001513493A (ja) * 1997-08-09 2001-09-04 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 経鼻投与用組成物
US6015832A (en) * 1997-12-31 2000-01-18 The Regents Of The University Of Michigan Methods of inactivating bacteria including bacterial spores
JP2000109425A (ja) * 1998-10-02 2000-04-18 Lion Corp 花粉破裂防止剤、花粉破裂防止方法及び粘膜用洗浄剤
US6506803B1 (en) * 1999-04-28 2003-01-14 Regents Of The University Of Michigan Methods of preventing and treating microbial infections
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US6296882B1 (en) * 2000-06-12 2001-10-02 Manuel Viamonte, Jr. Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, and lemon oil
AUPQ875700A0 (en) * 2000-07-13 2000-08-03 Reflex Research Limited Combination compositions

Also Published As

Publication number Publication date
DE602004010130T2 (de) 2008-09-18
EP1648412A1 (de) 2006-04-26
JP5604395B2 (ja) 2014-10-08
PL1648412T3 (pl) 2008-04-30
ATE378038T1 (de) 2007-11-15
ES2297442T3 (es) 2008-05-01
JP5037939B2 (ja) 2012-10-03
EP1648412B1 (de) 2007-11-14
JP2012051892A (ja) 2012-03-15
WO2005004843A1 (en) 2005-01-20
JP2007526885A (ja) 2007-09-20

Similar Documents

Publication Publication Date Title
WO2006031606A3 (en) Carboxamide spirolactam cgrp receptor antagonists
PH12020550051A1 (en) Glp-1 compositions and uses thereof
ATE432278T1 (de) Verbindungen zur behandlung von krankheiten
WO2011013133A3 (en) Novel biopesticide compositions and method for isolation and characterization of same
ATE389662T1 (de) Cardioprotektive phosphonate
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
WO2006029153A3 (en) Monocyclic anilide spirolactam cgrp receptor antagonists
NO20062767L (no) Immunoglobuliner
NO20092470L (no) Substituerte diazepanforbindelser som orexinreseptorantagonister
WO2008036932A3 (en) Compositions and methods comprising boswellia species
WO2006081363A3 (en) Oral formulations for delivery of catecholic butanes including ndga compounds
ATE406161T1 (de) Kombination aus tenofovir, ritonavir und tmc114
DE10193689D2 (de) Retardpartikeldispersion
ATE457736T1 (de) Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid
TW200716172A (en) Pharmaceutical compositions for treating lower motor neuron diseases
NO20055612L (no) Anti-inflammatoriske fosfonatforbindelser
WO2007005672A3 (en) Treatment and prevention of respiratory diseases and conditions
ATE469657T1 (de) Immunstimulatorische kombination zur vorbeugung und behandlung von hepatitis c
DE602004010130D1 (de) Mikroemulsionen und ihre verwendung zur prävention von erkrankungen der atemwege
ZA200802026B (en) Use of cni-od formulations for controlling white fly
EA200970597A1 (ru) Новые бис(диалкиламиды), способ получения и применения
EP1238587A3 (de) Biopestizid-Zusammensetzungen
ATE358992T1 (de) Enteralpräparat zur vorbeugung gegen bzw. behandlung von sepsis
ATE503476T1 (de) Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch infektion mit yersinia spp ausgelöst sind
ATE417035T1 (de) Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition